“…At the same time, P57 KIP2 has been used as a predictive factor, to differentiate periods in many kinds of tumors. There have been reports that P57 KIP2 undergoes frequent loss of heterozygosity in breast, bladder, lung, ovarian, kidney, and testicular carcinomas (Seizinger et al, 1991) . The p57 gene is paternally imprinted in humans , and loss of the maternal (expressed) allele occurs in a variety of pediatric tumors, including Wilms' tumor (Hatada et al, 1996), and in adult lung tumors (Kondo et al, 1996).…”